Frontiers in Oncology · 2021 · 12 citations · 30 references
WBRT plus chemotherapy improved OS in patients with BM from SCLC as compared to BSC. Chemotherapy alone and WBRT alone did not show survival benefits. This retrospective study suggests that SCLC patients with BM who receive WBRT combined with chemotherapy have a better outcome than those receiving BSC alone.
30
Eric L. Chang, Jeffrey S. Wefel, Kenneth R. Hess et al. · The Lancet Oncology · 2009 · 2.4K citations
Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations
Platinum–etoposide Versus Platinum–etoposide, Medicine, Pharmacology +6